Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancermedicalscience

Please Note: The journal is closed for new submissions until 1st Sept 2026 (to catch up with record numbers in recent months).

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

NB:

  • The journal does not accept case reports
  • From 6 April 2026 APCs will apply to manuscripts submitted from countries classified as upper-middle-income or high-income.
  • Manuscripts may be declined after 60 days if suitable reviewers cannot be secured, to minimise delays and allow authors to submit their work elsewhere.
Articles
Editorials
Special issues
Author interviews
497-highlights-from-the-seventh-european-multidisciplinary-colorectal-cancer-congress-emccc-2014
Cornelis JA Punt, Iris D Nagtegaal, Cornelis J van de Velde, Regina Beets-Tan, Annemieke Cats, Nicoline Hoogerbrugge, Corrie A Marijnen
488-eurocan-platform-meeting-european-recommendations-for-biomarker-based-chemoprevention-trials
Linda Cairns
486-t-helper-1-immunoreaction-influences-survival-in-muscle-invasive-bladder-cancer-proof-of-concept
Alexandre Ingels, Rafael E Sanchez Salas, Vincent Ravery, Gaëlle Fromont-Hankard, Pierre Validire, Jean-Jacques Patard, Géraldine Pignot, Dominique Prapotnich, Fabien Olivier, Marc Galiano, Eric Barret, Francois Rozet, Nina Weber, Xavier Cathelineau
479-dramatic-response-to-dabrafenib-and-trametinib-combination-in-a-braf-v600e-mutated-cholangiocarcinoma-implementation-of-a-molecular-tumour-board-and-next-generation-sequencing-for-personalized-medicine
Arturo Loaiza-Bonilla, Erica Clayton, Emma Furth, Mark O'Hara, Jennifer Morrissette
473-common-genetic-variants-in-pre-micrornas-and-risk-of-breast-cancer-in-the-north-indian-population
C Bansal, KL Sharma, Sanjeev Misra, AN Srivastava, Balraj Mittal, US Singh
446-sympathetic-nervous-system-alterations-with-her2-antagonism-an-early-marker-of-cardiac-dysfunction-with-breast-cancer-treatment
Carrie G Lenneman, Wissam M Abdallah, Holly M Smith, Vandana Abramson, Ingrid A Mayer, Cheri Silverstein, Julie Means-Powell, Sachin Y Paranjape, Daniel Lenihan, Douglas B Sawyer, Satish R Raj
410-expression-of-the-metastasis-suppressor-brms1-in-uveal-melanoma
Bruna V Ventura, Carlos Quezada, Shawn C Maloney, Bruno F Fernandes, Emilia Antecka, Claudia Martins, Silvin Bakalian, Sebastian di Cesare, Miguel N Burnier Jr
394-serum-cytokeratin-19-fragment-in-advanced-lung-cancer-could-we-eventually-have-a-serum-tumor-marker
Ahmed El Bastawisy, Mahmoud El azzouny, Gamal Mohammed, Ahmed Awad allah, Eman Behiry
386-highlights-from-the-2013-national-cancer-research-institute-conference
Ian Lewis
380-the-impact-of-the-oncotype-dx-recurrence-score-on-treatment-decisions-and-clinical-outcomes-in-patients-with-early-breast-cancer-the-maccabi-healthcare-services-experience-with-a-unified-testing-policy
Nava Siegelmann-Danieli, Barbara Silverman, Aviad Zick, Anat Beit-Or, Itzhak Katzir, Avi Porath

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation